Physician profile
Michael Ra
NPI 1619132123
$1,804.18
in general payments reported to CMS, 2019-2025
10 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,021 · 2021: $124 · 2022: $153 · 2024: $375 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $939.74 | 2019 | |
| Medtronic, INC. | $447.44 | 2024-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Mazor X System |
| Boston Scientific Corporation | $136.75 | 2021-2025 | Intracept |
| Spr Therapeutics, INC | $100.17 | 2022 | |
| Depuy Synthes Sales INC. | $91.93 | 2019-2022 | |
| Vertos Medical, INC. | $29.33 | 2022-2024 | Mild Device Kit |
| Si-Bone, INC. | $17.72 | 2021 | |
| Horizon Therapeutics Plc | $14.57 | 2019 | |
| Pacira Therapeutics, INC. | $13.83 | 2019 | |
| Sunovion Pharmaceuticals INC. | $12.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.